Enrollment nearing completion in Phase 2 basket study of WAL0921; initial data from diabetic kidney disease cohorts to be presented in fourth quarter 2026 Data from Phase 1+ study of WAL0921 to be ...

New Cardiovascular Device Approved in Japan: Elixir Medical Announces Regulatory Approval of DynamX® Coronary Bioadaptor ...

SAN RAFAEL, Calif., Sept. 14, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that the company has ...

After years of price pressures, the trade group argues “the economics of generics have deteriorated to the point where ...

Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United ...

MISSISSAUGA, ON, Sept. 14, 2026 /CNW/ -- Medline Canada has entered into an agreement to develop a new warehouse and ...

Said Dr. Willsey, “The participant and the Paradromics team have achieved a major milestone by demonstrating the ability to ...

Catalyst MedTech today announced it will showcase its expanded nuclear cardiology portfolio at the 31st Annual Scientific ...

BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable ...

Oncology Research Program ( ORP) today announced funding awards for quality improvement initiatives in metastatic prostate ...

This guide explores the evolving role of podcasts, webinars, and thought leadership programs in biopharma and provides ...

BioNTech, Summit Therapeutics, GSK and Roche have made a splash at the ongoing World Conference on Lung Cancer taking place ...